Re-audit plan
Captured in the improvement plan and reflected in outputs
Baseline criterion compliance
Snapshot from current submissions — comparison with re-audit data appears once a re-audit cycle is opened
| Criterion | Baseline | Target | Gap to target |
|---|---|---|---|
| Structured medication review completed | 100% | 95% | +5 |
| Indication documented for regular medicines | 100% | 95% | +5 |
| Dose appropriateness reviewed | 50% | 95% | −45 |
| Drug interactions reviewed | 100% | 95% | +5 |
| Renal dosing reviewed / renal function documented | 50% | 95% | −45 |
| Hepatic considerations reviewed | 100% | 90% | +10 |
| Medicines reconciliation completed | 100% | 95% | +5 |
| Falls risk considered where relevant | 100% | 90% | +10 |
| Patient/carer involved in the review | 50% | 90% | −40 |
| STOPP/START considered where appropriate | 50% | 90% | −40 |
| Deprescribing opportunities identified | 100% | 80% | +20 |
| Pharmacy review completed | 100% | 90% | +10 |
| Consultant review completed | 50% | 80% | −30 |
| Medication changes documented | 100% | 95% | +5 |
| Rationale for changes documented | 50% | 95% | −45 |
| Monitoring plan documented | 100% | 90% | +10 |
| GP communication documented | 50% | 90% | −40 |
| Patient counselling documented | 50% | 90% | −40 |
| Action plan documented | 100% | 95% | +5 |
| Follow-up need assessed/documented | 100% | 90% | +10 |